Skip to main content
Premium Trial:

Request an Annual Quote

Kinaxo, Roche Dx Sign Second Collaboration

NEW YORK (GenomeWeb News) – Kinaxo Biotechnologies said today that it will collaborate with Roche Diagnostics to support Roche’s development of new targeted treatment-related technologies.

Under the agreement, which is the second collaboration between the companies, Kinaxo will use its PhosphoScout phosphoproteomics technology to support targeted treatment development.

PhosphoScout enables identification of regulated protein phosphorylation sites, and does not require antibodies for detection, enabling phosphoproteome analysis across signaling pathways, Martinsried, Germany-based Kinaxo said.

Kinaxo’s chemical proteomics and quantitative phosphoproteomics tools support drug mode-of-action analysis, drug repositioning, cellular target profiling, and target deconvolution, according to the company.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.